Delivery of an anti-fibroblastic protein nanoparticle encoding LIGHT stimulates TLS formation by increasing CD8+ T cell recruitment, chemokine production, and tumor vasculature normalization, while concurrently inhibiting aberrant collagen secretion by fibroblasts [287]. Here, CD8A is linked to neoplasm.